CD274 and non-small cell lung carcinoma: Separate analysis of samples from NSCLC and HNSCC cohorts independently confirmed the reliability of the ≥25 % staining cut-off and exclusion of cytoplasmic tumor cell staining, immune cell staining, and staining intensity from the analysis of PD-L1 staining status.